Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003060112 | SCV003439972 | pathogenic | Cerebral cavernous malformation 2 | 2022-05-25 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with cerebral cavernous malformations (PMID: 17277691). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln218Argfs*74) in the CCM2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CCM2 are known to be pathogenic (PMID: 18300272, 24689081). |